BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1384898)

  • 1. Cytotoxic drug and cytotoxic drug/G-CSF mobilization of peripheral blood stem cells and their use for autografting.
    Teshima T; Harada M; Takamatsu Y; Makino K; Taniguchi S; Inaba S; Kondo S; Tanaka T; Akashi K; Minamishima I
    Bone Marrow Transplant; 1992 Sep; 10(3):215-20. PubMed ID: 1384898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood stem cell mobilization with chemotherapy and granulocyte-colony stimulating factor in patients with hematological malignancies.
    Watanabe S; Mukaiyama T; Ogawa Y; Kawada H; Ichikawa Y
    Tokai J Exp Clin Med; 1994 Dec; 19(3-6):143-55. PubMed ID: 7570686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of infused CFU-GM and CFU-Mk mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation.
    Takamatsu Y; Harada M; Teshima T; Makino S; Inaba S; Akashi K; Shibuya T; Niho Y
    Exp Hematol; 1995 Jan; 23(1):8-13. PubMed ID: 7527786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of autografting using mobilized peripheral blood stem cells with and without granulocyte colony-stimulating factor in malignant lymphomas.
    Brice P; Divine M; Marolleau JP; Haioun C; Dalcortivo L; Sitthy X; Beaujean F; Norol F; Benbunan M; Reyes F
    Bone Marrow Transplant; 1994 Jul; 14(1):51-5. PubMed ID: 7524907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of recombinant human GM-CSF to enhance peripheral progenitor cell yield for autologous transplantation.
    Ho AD; Haas R; Korbling M; Dietz M; Hunstein W
    Bone Marrow Transplant; 1991; 7 Suppl 1():13-7. PubMed ID: 1675138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors.
    Kotasek D; Shepherd KM; Sage RE; Dale BM; Norman JE; Charles P; Gregg A; Pillow A; Bolton A
    Bone Marrow Transplant; 1992 Jan; 9(1):11-7. PubMed ID: 1347478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autografting with peripheral blood stem cells mobilized by sequential interleukin-3/granulocyte-macrophage colony-stimulating factor following high-dose chemotherapy in non-Hodgkin's lymphoma.
    Haas R; Ehrhardt R; Witt B; Goldschmidt H; Hohaus S; Pförsich M; Ehrlich H; Färber L; Hunstein W
    Bone Marrow Transplant; 1993 Dec; 12(6):643-9. PubMed ID: 7511017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor.
    Shimazaki C; Oku N; Ashihara E; Okawa K; Goto H; Inaba T; Ito K; Fujita N; Tsuji H; Murakami S
    Bone Marrow Transplant; 1992 Oct; 10(4):341-6. PubMed ID: 1384902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose granulocyte colony-stimulating factor enables the efficient collection of peripheral blood stem cells after disease-oriented, conventional-dose chemotherapy for breast cancer, malignant lymphoma and germ cell tumor.
    Kohno A; Takeyama K; Narabayashi M; Okamoto R; Adachi I; Tobinai K; Shimoyama M
    Bone Marrow Transplant; 1995 Jan; 15(1):49-54. PubMed ID: 7538002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant.
    Bolwell BJ; Goormastic M; Yanssens T; Dannley R; Baucco P; Fishleder A
    Bone Marrow Transplant; 1994 Dec; 14(6):913-8. PubMed ID: 7536072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mobilization of circulating hematopoietic stem cells by granulocyte colony stimulating factor after chemotherapy in multiple myeloma].
    Ohler L; Scholten C; Reiter E; Tiefengraber E; Jäger U; Strobl H; Lechner K; Höcker P; Geissler K
    Wien Klin Wochenschr; 1993; 105(20):580-4. PubMed ID: 7505076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood progenitors mobilised by G-CSF (filgrastim) and reinfused as unprocessed autologous whole blood shorten the pancytopenic period following high-dose melphalan in multiple myeloma.
    Ossenkoppele GJ; Jonkhoff AR; Huijgens PC; Nauta JJ; van der Hem KG; Dräger AM; Langenhuijsen MM
    Bone Marrow Transplant; 1994 Jan; 13(1):37-41. PubMed ID: 7517255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment.
    Bolwell BJ; Fishleder A; Andresen SW; Lichtin AE; Koo A; Yanssens T; Burwell R; Baucco P; Green R
    Bone Marrow Transplant; 1993 Dec; 12(6):609-14. PubMed ID: 7511016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with peripheral blood stem cell collection for autografts in children with active cancer.
    Takaue Y; Watanabe T; Abe T; Okamoto Y; Saito S; Shimizu T; Sato J; Hirao A; Suzue T; Koyama T
    Bone Marrow Transplant; 1992 Sep; 10(3):241-8. PubMed ID: 1358378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose cyclophosphamide followed by GM-CSF is a safe and effective procedure for the recruitment of trilineage circulating progenitor cells.
    Patrone F; Ballestrero A; Balleari E; Bogliolo F; Brema F; Ferrando F; Ghio R; Timitilli S
    Haematologica; 1992; 77(6):457-62. PubMed ID: 1289182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants.
    To LB; Roberts MM; Haylock DN; Dyson PG; Branford AL; Thorp D; Ho JQ; Dart GW; Horvath N; Davy ML
    Bone Marrow Transplant; 1992 Apr; 9(4):277-84. PubMed ID: 1350938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor.
    Schwartzberg LS; Birch R; Hazelton B; Tauer KW; Lee P; Altemose R; George C; Blanco R; Wittlin F; Cohen J
    J Hematother; 1992; 1(4):317-27. PubMed ID: 1285381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recovery of hematopoiesis after high-dose chemotherapy and peripheral blood stem cell autografts in children].
    Sato J; Takaue Y; Okamoto Y; Saito S; Hirao A; Matsunaga K; Shimizu T; Abe T; Watanabe T; Kawano Y
    Rinsho Ketsueki; 1992 May; 33(5):637-45. PubMed ID: 1352832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.